Superantigen reactive Vbeta6+ T cells induce perforin/granzyme B mediated caspase-independent apoptosis in tumour

S Müerköster1, M A Weigand, C Choi

  • 1Division of Cellular Immunology, G0100, Tumorimmunology Program, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

Insights

Viral superantigen 7 triggers rapid T cell-mediated killing of lymphoma cells via perforin and granzyme B, bypassing caspases and mitochondria. This mechanism, combined with nitric oxide, may explain effective graft-vs-leukemia responses.

Area of Science:

  • Immunology
  • Cell Biology
  • Oncology

Background:

  • Endogenous viral superantigen 7 (VSA7) is a target antigen on ESb-MP lymphoma cells in DBA/2 mice.
  • Allogeneic Vbeta6+ T cells recognize VSA7 and mediate graft-vs-leukemia (GvL) reactivity.
  • Understanding the precise killing mechanism is crucial for GvL therapy optimization.

Purpose of the Study:

  • To elucidate the mechanism of superantigen-specific tumor cell lysis mediated by Vbeta6+ T cells.
  • To differentiate this rapid lysis from other known apoptotic pathways.
  • To explore potential synergistic interactions in a GvL model.

Main Methods:

  • Co-incubation of Vbeta6+ T cells with VSA7+ ESb-MP tumor cells.
  • Assessment of apoptosis using Annexin V staining and DNA fragmentation assays.
  • Analysis of cell death pathways, including death-inducing ligands, perforin/granzyme B, nitric oxide, mitochondria, and caspases.

Main Results:

  • VSA7+ ESb-MP cells exhibited rapid apoptosis (Annexin V-positivity, DNA fragmentation) within 10 minutes of co-incubation with Vbeta6+ T cells.
  • This rapid cell death was mediated by perforin and granzyme B, independent of CD95L, TRAIL, TNF, mitochondria, or caspases.
  • Nitric oxide induced a slower, caspase- and mitochondria-dependent apoptosis in the same tumor cells.
  • A synergistic effect between T cell-mediated lysis and nitric oxide was observed.

Conclusions:

  • Viral superantigen 7-specific cytotoxic T lymphocytes induce rapid tumor cell apoptosis via a non-canonical perforin/granzyme B pathway.
  • This rapid lysis mechanism bypasses conventional mitochondrial and caspase-dependent apoptosis.
  • Synergy between cytotoxic T lymphocytes and nitric oxide may contribute to effective immune rejection in GvL models, including metastatic cancer.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...